BCG
PFE icon

Breakwater Capital Group’s Pfizer PFE Stock Holding History

Breakwater Capital Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.61M Sell
66,911
-1,215
-2% -$31.8K 0.19% 121
2026
Q1 		$1.91M Sell
68,126
-2,296
-3% -$61.1K 0.26% 89
2025
Q4 		$1.75M Sell
70,422
-1,545
-2% -$39K 0.24% 98
2025
Q3 		$1.83M Sell
71,967
-7,703
-10% -$190K 0.27% 86
2025
Q2 		$1.93M Buy
79,670
+3,345
+4% +$78K 0.31% 76
2025
Q1 		$1.93M Buy
76,325
+3,144
+4% +$82.3K 0.34% 73
2024
Q4 		$1.94M Sell
73,181
-7,358
-9% -$200K 0.39% 66
2024
Q3 		$2.33M Buy
80,539
+2,290
+3% +$66.8K 0.47% 58
2024
Q2 		$2.19M Buy
78,249
+31,973
+69% +$880K 0.5% 53
2024
Q1 		$1.28M Buy
46,276
+1,163
+3% +$32.3K 0.32% 75
2023
Q4 		$1.28M Buy
45,113
+3,050
+7% +$92.2K 0.36% 71
2023
Q3 		$1.28M Buy
42,063
+5,779
+16% +$204K 0.44% 62
2023
Q2 		$1.33M Buy
36,284
+10,730
+42% +$418K 0.49% 59
2023
Q1 		$1.04M Buy
25,554
+1,976
+8% +$85.3K 0.44% 61
2022
Q4 		$1.21M Buy
+23,578
New +$1.13M 0.63% 48

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Breakwater Capital Group's PFE Position: Q2 2026 in Review

Breakwater Capital Group reduced its Pfizer (PFE) stake by 1.8% in Q2 2026, selling an estimated $31.8K and leaving 66,911 shares worth $1.61M. The position accounts for 0.19% of the portfolio, ranked #121.

Breakwater Capital Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.33M in Q3 2024. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Breakwater Capital Group held 66,911 shares of Pfizer worth $1.61M as of Q2 2026.
  • Breakwater Capital Group sold 1,215 Pfizer shares in Q2 2026, an estimated $31.8K.
  • Pfizer made up 0.19% of Breakwater Capital Group's portfolio in Q2 2026, its #121 holding.
  • Breakwater Capital Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Breakwater Capital Group's Pfizer position peaked at $2.33M in Q3 2024.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Breakwater Capital Group's 13F filing for Q2 2026, filed 8 Jul 2026.